Do company visits by institutional investors mitigate managerial myopia in R&D investment? Evidence from China

被引:17
|
作者
Luo, Yonggen [1 ]
Wu, Huiying [2 ]
Ying, Sammy Xiaoyan [3 ]
Peng, Qiuping [4 ]
机构
[1] Guangdong Univ Finance & Econ, Sch Accounting, Guangzhou 510320, Guangdong, Peoples R China
[2] Western Sydney Univ, Sch Business, Parramatta, NSW 2150, Australia
[3] Univ Newcastle, Newcastle Business Sch, 55 Elizabeth St, Sydney, NSW 2000, Australia
[4] South China Univ Technol, Sch Business Adm, Guangzhou 510000, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Managerial myopia; R&D investment; Institutional investor; Company visit; China; CORPORATE GOVERNANCE; CEO DUALITY; ORGANIZATIONAL PERFORMANCE; OWNERSHIP STRUCTURE; AGENCY COSTS; INNOVATION; EARNINGS; FAMILY; BOARD; FIRM;
D O I
10.1016/j.gfj.2021.100694
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
This study investigates the effects of company visits by institutional investors on managerial myopia about investment in research and development (R&D) in China. We find that company visits increase R&D spending. We also find that this increase is more pronounced for companies that have an entrenched chief executive officer (CEO), as indicated by longer CEO tenure and CEO duality, and for companies that face less intense market competition. The results further show that the increase in R&D spending is more pronounced for companies that have larger institutional ownership, are invested by long-term oriented institutions, are in the high-tech industry, and are state owned. These findings attest to the governance role of institutional investors.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] How do investors trade R&D-intensive Stocks? Evidence from hedge funds and other institutional investors
    Alldredge, Dallin M.
    Caglayan, Mustafa O.
    Celiker, Umut
    JOURNAL OF BANKING & FINANCE, 2022, 134
  • [22] Academic Independent Director Abnormal Resignations and R&D Investment: Evidence from China
    Cao, Shaopeng
    Wu, Ji
    Wang, Chunfeng
    Fang, Zhenming
    Cui, Xin
    EMERGING MARKETS FINANCE AND TRADE, 2023, 59 (01) : 238 - 264
  • [23] Institutional investors and the moral hazards of technology investment: Evidence from China
    Shahzad, Umeair
    Liu, Jing
    Pang, Tingyun
    Luo, Fukai
    ECONOMICS OF INNOVATION AND NEW TECHNOLOGY, 2023, 32 (02) : 223 - 249
  • [24] Multinationality, R&D and productivity: Evidence from the top R&D investors worldwide
    Castellani, Davide
    Montresor, Sandro
    Schubert, Torben
    Vezzani, Antonio
    INTERNATIONAL BUSINESS REVIEW, 2017, 26 (03) : 405 - 416
  • [25] How Do Institutional Investors Affect Corporate Performance? Evidence from Private Placements in China
    Tao, Qizhi
    Liu, Ming
    Feng, Qingchen
    Zhu, Yingjun
    EMERGING MARKETS FINANCE AND TRADE, 2018, 54 (15) : 3454 - 3469
  • [26] Do site visits mitigate corporate fraudulence? Evidence from China
    Su, Fei
    Feng, Xu
    Tang, Songlian
    INTERNATIONAL REVIEW OF FINANCIAL ANALYSIS, 2021, 78
  • [27] Commercial Credit, Financial Constraints, and Firm's R&D Investment: Evidence from China
    Zou, Zongsen
    Teng, Xiangyu
    Liu, Xindi
    Wang, Meng
    JOURNAL OF THE KNOWLEDGE ECONOMY, 2024, 15 (02) : 7257 - 7279
  • [28] Does the annual report readability improve corporate R&D investment? Evidence from China
    Du, Ya-Guang
    Li, Shu
    Kuo, Nan-Ting
    Li, Dan
    INTERNATIONAL JOURNAL OF DISCLOSURE AND GOVERNANCE, 2024,
  • [29] External financing sensitivities and inefficient R&D investment: Evidence from China
    Chiu, Sheng-Hsiung
    Lin, Tzu-Yu
    Pan, Lu
    RESEARCH IN INTERNATIONAL BUSINESS AND FINANCE, 2024, 70
  • [30] The firms' perception of global uncertainty and R&D investment: Evidence from China
    Lu, Bing
    Ren, Wanwan
    Liu, Wenge
    RESEARCH IN INTERNATIONAL BUSINESS AND FINANCE, 2025, 73